| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2011/11/24 | 06 : 10 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/24 | 04 : 01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/23 | 15 : 39 | Dow Jones News | Roche Buys Shares In Tender Offer For Anadys Pharmaceuticals | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/16 | 20 : 02 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/16 | 07 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/15 | 06 : 55 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/09 | 20 : 05 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/09 | 20 : 05 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/08 | 22 : 16 | Marketwired | Acquisition Spotlight Shines on Hepatitis C Drug Developers | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/08 | 07 : 01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/08 | 06 : 05 | PR Newswire (US) | Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/11/05 | 05 : 34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/31 | 22 : 30 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/26 | 21 : 16 | Marketwired | Positive Test Results and Acquisitions Drive Shares of Exelixis and Anadys Higher | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/26 | 19 : 02 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/26 | 06 : 08 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/26 | 05 : 25 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/25 | 22 : 34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/25 | 05 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/21 | 23 : 53 | Business Wire | The Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/21 | 04 : 39 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 22 : 30 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 19 : 08 | Dow Jones News | Roche MS Drug's Good Test Results Boost Pipeline's Prospects | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 08 : 00 | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 06 : 14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 05 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/20 | 02 : 12 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/19 | 12 : 30 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/18 | 22 : 00 | Marketwired | Analyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LP | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 2011/10/18 | 09 : 32 | Business Wire | Robbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |